These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 13646447)
1. The histopathological changes induced by the nitrogen mustards in the lymphomas: a brief review of the literature. CAPUTI S R I Med J; 1959 Apr; 42(4):242-5 passim. PubMed ID: 13646447 [No Abstract] [Full Text] [Related]
2. [Treatment of hematologic neoplasms with nitrogen oxide mustards]. HORLIN W; SCHMITT W Dtsch Med Wochenschr; 1957 Feb; 82(7):247-50. PubMed ID: 13427484 [No Abstract] [Full Text] [Related]
3. [Histopathological aspect of the lymph nodes in Hodgkin's disease treated with nitrogen mustards]. GENIS GALVEZ JM; GASALLA CHACON JM Medicina (Madr); 1953 Aug; 21(2:2):95-109. PubMed ID: 13110542 [No Abstract] [Full Text] [Related]
4. [Treatment of Hodgkin's disease with nitrogen mustards]. CHEVALLIER P; BILSKI-PASQUIER G; CHRISTOL D; BOIRON M Sem Hop; 1954 Feb; 30(13):774-7. PubMed ID: 13146192 [No Abstract] [Full Text] [Related]
5. [Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions]. INTROZZI P; MARINONE G Haematologica; 1953; 37(11):1195-1274. PubMed ID: 13151517 [No Abstract] [Full Text] [Related]
6. [Histopathological aspect of the lymph nodes in Hodgkin's disease treated with nitrogen mustards]. GENIS GALVEZ JM; CASALLA CHACON JM Med Colon; 1953 Jun; 21(6):652-68. PubMed ID: 13098709 [No Abstract] [Full Text] [Related]
7. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid]. BERNARD J; MATHE G; WEIL M Sang; 1957; 28(1):80-2. PubMed ID: 13432604 [No Abstract] [Full Text] [Related]
8. Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases. HOCHMAN A; ICKOWICZ M Br J Radiol; 1954 Aug; 27(320):467-9. PubMed ID: 13182191 [No Abstract] [Full Text] [Related]
9. [Treatment of malignant lymphogranulomatosis with intraarterial injections of nitrogen mustards and chloramphenicol]. DESAIVE P; CLOSON J; LAVIGNE J Rev Med Liege; 1954 Feb; 9(4):112-20. PubMed ID: 13167862 [No Abstract] [Full Text] [Related]
10. [Therapeutic use of embichin]. SOROKIN NM Klin Med (Mosk); 1954 Jun; 32(6):75-7. PubMed ID: 13192973 [No Abstract] [Full Text] [Related]
11. [Therapeutic use of embikhin in lymphogranulomatosis]. SHAMINA EV Vopr Onkol; 1955; 1():232-4. PubMed ID: 13456431 [No Abstract] [Full Text] [Related]
12. [Nitrogen mustard and Hodgkin's disease; case report]. PERIERA JR Port Med; 1953 Nov; 37(11):645-58. PubMed ID: 13120577 [No Abstract] [Full Text] [Related]
13. [Role of nitrogen mustard in the treatment of malignant lymphogranuloma]. CROIZAT P; PAPILLON J; PINET F J Radiol Electrol Arch Electr Medicale; 1953; 34(1-2):83-4. PubMed ID: 13085392 [No Abstract] [Full Text] [Related]
14. [Effect of x-rays and nitrogen mustards in the treatment of Hodgkin's disease]. PIEMONTE M J Radiol Electrol Arch Electr Medicale; 1953; 34(1-2):80-2. PubMed ID: 13085391 [No Abstract] [Full Text] [Related]
15. [Experimental and clinical studies on the toxic and therapeutic effect of both nitrogen mustard compounds, trichlortriethylamine and dichloro-diethylamine]. GOHR H; GORGES T; BOLDER H Z Gesamte Inn Med; 1953 Aug; 8(15):692-6. PubMed ID: 13170111 [No Abstract] [Full Text] [Related]
16. [Action of cytotoxic drugs in Hodgkin-Sternberg malignant granuloma; electrophoretic changes in blood]. CHIARIONI T; FRACASSO I; NARDI E G Clin Med; 1957 Feb; 38(2):245-69. PubMed ID: 13448428 [No Abstract] [Full Text] [Related]
17. [Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms]. INGRASSIA G; VASILE B Haematologica; 1951; 35(10):907-53. PubMed ID: 14906882 [No Abstract] [Full Text] [Related]
18. [Observations on three years of clinical experience with nitrogen mustard]. CUCINOTTA U G Ital Chemioter; 1954; 1(1):175-7. PubMed ID: 13191617 [No Abstract] [Full Text] [Related]
19. [The hydrochloride of 2,2'-dichloro-N-methyldiethylamine N-oxide in the therapy of malignant blood diseases]. CONSOLI G G Ital Chemioter; 1954; 1(1):154-6. PubMed ID: 13191611 [No Abstract] [Full Text] [Related]
20. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative]. ZULIK R Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105 [No Abstract] [Full Text] [Related] [Next] [New Search]